Ignite Creation Date:
2025-12-25 @ 1:03 AM
Ignite Modification Date:
2026-03-21 @ 7:19 PM
Study NCT ID:
NCT03886493
Status:
TERMINATED
Last Update Posted:
2021-10-15
First Post:
2019-03-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
J18116
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |